Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 Diabetes

• Status: Unknown status
• Trial end date: 2009-04-01

Summary

Men with metabolic syndrome often have lower than normal testosterone levels and low testosterone levels have been suggested to predispose for development of type2 diabetes. The aim of the study is to evaluate if normalisation of serum testosterone levels in men with metabolic syndrome (Abdominal obesity, hypertension, dyslipidemia, insulin resistance and pre-diabetes or overt type diabetes)improves sensitivity to insulin and improves the signs of the metabolic syndrome

• Phase: Phase 3

Details

• Lead Sponsor: Karolinska Institutet
• Collaborators: Charite University, Berlin, Germany; Endokrinologikum Hamburg; Karolinska University Hospital; Krankenanstalt der Stadt Wien Rudolfstiftung; Krankenhaus der Stadt Wien Lainz; Medical University of Graz; Medical University of Vienna; Medizinische Universität Wien; Southern Hospital Stockholm; Universitätsklinikum MünsterInstitut für Reproduktionsmedizin; UroHealth Skövde
• Treatments: Methyltestosterone; Testosterone; Testosterone 17 beta-cypionate; Testosterone enanthate; Testosterone undecanoate